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Available online 18 March 2018Human stromal stem cells (hMSCs) differentiate into adipocytes that play a role in skeletal tissue homeostasis
and whole body energy metabolism. During adipocyte differentiation, hMSCs exhibit signiﬁcant changes in cell
morphology suggesting changes in cytoskeletal organization. Here, we examined the effect of direct modulation
of actin microﬁlament dynamics on adipocyte differentiation. Stabilizing actin ﬁlaments in hMSCs by siRNA-me-
diated knock down of the twomain actin depolymerizing factors (ADFs): Coﬁlin 1 (CFL1) and Destrin (DSTN) or
treating the cells by Phalloidin reduced adipocyte differentiation as evidenced by decreased number of mature
adipocytes and decreased adipocyte speciﬁc gene expression (ADIPOQ, LPL, PPARG, FABP4). In contrast, disrup-
tion of actin cytoskeleton by Cytochalasin D enhanced adipocyte differentiation. Follow up studies revealed that
the effects of CFL1 on adipocyte differentiation depended on the activity of LIMdomain kinase 1 (LIMK1)which is
the major upstream kinase of CFL1. Inhibiting LIMK by its speciﬁc chemical inhibitor LIMKi inhibited the phos-
phorylation of CFL1 and actin polymerization, and enhanced the adipocyte differentiation. Moreover, treating
hMSCs by Cytochalasin D inhibited ERK and Smad2 signaling and this was associated with enhanced adipocyte
differentiation. On the other hand, Phalloidin enhanced ERK and Smad2 signaling, but inhibited adipocyte differ-
entiation which was rescued by ERK speciﬁc chemical inhibitor U0126. Our data provide a link between
restructuring of hMSCs cytoskeleton and hMSCs lineage commitment and differentiation.





Human stromal stem cells1. Introduction
The cytoskeleton is a system of intracellular ﬁlaments crucial for cell
shape, adhesion, growth, division and motility (Stossel, 1993;
Wickstead and Gull, 2011). As one of themajor component of cytoskel-
eton, actin ﬁlaments form a highly dynamic network composed of
actin polymers and a large variety of associated proteins (Schmidt and
Hall, 1998). The actin proteins exist within cells in either globular/
monomer (G-actin) or ﬁlamentous (F-actin) form and thus in dynamic
transitions between depolymerization and polymerization status (Ono,
2007). Actin depolymerization factor (ADF) coﬁlin is a family of actin
binding proteins with actin ﬁlaments depolymerization function
(Bamburg et al., 1980;Nishida et al., 1984). Inmammals, the coﬁlin fam-
ily consists of three highly similar paralogs: Coﬁlin-1 (CFL1, non-muscle
coﬁlin, n-coﬁlin), Coﬁlin-2 (CFL2, muscle coﬁlin, m-coﬁlin) and destrin
(DSTN). The activity of coﬁlins is regulated by phosphorylation,spital, Winslowsparken 25, 1th
pen access article under the CC BY-Npolyphosphoinositide interaction, pH and interaction with other actin
binding proteins (Van Troys et al., 2008).
Human bonemarrow-derived stromal (Skeletal) stem cells (hMSCs)
are a group of clonogenic and multipotent cells capable of differentia-
tion into mesoderm-type cells e.g. osteoblast and adipocyte (Abdallah
and Kassem, 2008). During lineage speciﬁc differentiation, hMSCs ex-
hibit signiﬁcant changes inmorphology and actin cytoskeletal organiza-
tion (McBeath et al., 2004; Treiser et al., 2010; Yourek et al., 2007).
Previous studies have suggested that RhoA-ROCK (Ras homolog gene
family member A-Rho-associated protein kinase) signaling mediates
changes in cell shape and cytoskeletal tension regulating hMSC lineage
commitment (McBeath et al., 2004). A spheroidal morphology associ-
ated with a dispersed actin cytoskeleton with few focal adhesions en-
courages MSC differentiate into adipocytes whereas a stiff, spread
actin cytoskeleton with greater numbers of focal adhesions drives
MSC differentiate into osteoblasts (Mathieu and Loboa, 2012). The
changes in cell shape are caused by cytoskeletal changes due to actin
synthesis and reorganization (Antras et al., 1989; Spiegelman and
Farmer, 1982), and thusmodiﬁcation bymechanical forces or regulation
of relative kinases that change actin cytoskeletal dynamics, can regulate
cell differentiation (Arnsdorf et al., 2009; Kanzaki and Pessin, 2001;C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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not been widely utilized in differentiation studies of hMSCs.
We have previously reported that interfering with actin assembly
dynamics by knocking down coﬁlin-1 in hMSCs increased polymerized
actin that promoted osteoblast cell differentiation through amechanism
of enhancing focal adhesion kinase (FAK), p38 and c-Jun N-terminal ki-
nase (JNK) signaling (Chen et al., 2015). In the present study, we exam-
ined the effects of interfering in the actin cytoskeletal dynamics on the
regulation of adipocyte differentiation of hMSCs.
2. Materials and methods
2.1. Cell culture and adipocyte differentiation of hMSCs
Primary hMSCs were isolated from human bonemarrow aspirate or
adipocyte as described (Stenderup et al., 2004). As a model for primary
hMSCs, we employed the hMSCs-TERT cell (hMSCs here after) created
in our laboratory by overexpression of human telomerase reverse tran-
scriptase (hTERT) gene (Simonsen et al., 2002). Cells were cultured in
Minimal Essential Media (MEM) without Phenol red and L-glutamine,
supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM
Glutamax, 100 units/ml penicillin, and 100 μg/ml streptomycin
(Gibco-Invitrogen, Carlsbad, CA). For adipocyte differentiation, cells
were induced by adipogenic induction medium containing 10% horse
serum (Sigma), 100 nM dexamethasone (Sigma), 450μM IBMX (1-
methyl-3-isobutylxanthine, Sigma), 1 μM BRL (Cayman Chemical), 3
μg/ml insulin (Sigma). Media were changed every two days. For chem-
ical treatment experiment, before each medium change, the cells were
pre-treated with Cytochalasin D (Sigma, C8273) (1–20 μM) for 1 h or
Phalloidin (Sigma, P2141) (0-3 μM) for 3 h or DMSO as control. After
treatment, cells were washed once and incubated in adipogenic differ-
entiationmedium. In someexperiments, 1 μMLIMdomain kinase inhib-
itor (LIMKi) (Calbiochem) or 10 μM and 25 μM ERK inhibitor U0126
(Cell Signaling, #9903)was used continuouslywith adipocyte induction
medium during adipocyte differentiation, Oil red O staining for lipid
droplets formation in mature adipocytes was performed as described
(Abdallah et al., 2005).
2.2. Cell transfection
Small interfering RNA (siRNA) targeting DSTN (siR-DSTN), CFL1
(siR-CFL1) as well as non-targeting siRNA (siRNA negative control,
siR-Ctrl) were purchased from Ambion (Life Technology Inc.). siRNAs
were transfected into hMSCs-TERT at a ﬁnal concentration of 10 nM
by Lipofectamine2000 (Invitrogen) according to the manufacturer's in-
structions. 2–3 siRNAs for each gene were ordered and tested in the
study to conﬁrm the result.
2.3. Western blot analysis
Western blot analysis was performed as described previously (Chen
et al., 2015). Antibodies (total or phosphor) speciﬁc for CFL1, LIMK1,
Smad2, RhoA, Akt, JNK, p38, Smad1/5/8 were obtained from Cell Signal-
ing Technology; antibodies for total and phosphor-ERKwere purchased
from Santa Cruz; antibodies for DSTN, α-tubulin and actin were bought
from Sigma. All antibodies used at 1:1000 dilutions except α-tubulin
and actin antibodies (1:5000) in this study.
2.4. G-actin/F-actin assay
G-actin and F-actin in cells were quantitated by G-actin/F-actin in
vivo assay kit as manufacturer's instructions (Cytoskeleton® Inc.).
Cells were harvested by scraping in lysis and F-actin stabilization buffer.
The homogenates were incubated at 37 °C for 10 min, transferred to a
pre-warmed (37 °C) ultracentrifuge (SORVALL/Thermo Scientiﬁc) and
spun at 100,000g for 1 h at 37 °C to separate the globular (G)-actin(supernatant) and ﬁlamentous (F)-actin fractions (pellet). The pellets
were re-suspended in ice-cooled depolymerizing buffer. All samples
were diluted with appropriate loading buffer for Western blot analysis.
The blots were scanned and the protein bands were subjected to inten-
sity quantiﬁcation in ImageJ® software. Ratios of F-actin or G-actin in
cells were calculated according to the density.
2.5. Quantitative real-time reverse transcription polymerase chain reaction
(qRT-PCR)
For gene expression, total RNA was extracted with TriZoL reagent
(Invitrogen), and cDNA was prepared using RevertAid H Minus First
Strand cDNA Synthesis kit (Fermentas). The PCR products were visual-
ized in real-time using SYBR Green I Supermix (Bio-Rad) and an iCycle
instrument (Bio-Rad) using standard curve protocols, normalized to
beta-2-microglobulin (B2m). The quantitative data presented is an av-
erage of duplicate or triplicate per independent experiment.
2.6. Statistical analysis
Data are presented as mean ± standard deviation (SD). Statistical
testing was performed using Student's t-test to detect differences be-
tween groups. Differences were considered statistically signiﬁcant at P
b .05 (*) or P b .01 (**).
3. Results
3.1. Actin cytoskeleton is dissembled during adipocyte differentiation of
hMSCs
The success of adipocyte differentiation of hMSCs was evidenced by
the upregulation of both early and late adipocyte gene markers includ-
ing peroxisome proliferator activated receptor gamma 2 (PPARG2),
Adiponectin (ADIPOQ), lipoprotein lipase (LPL) and fatty acid binding
protein 4 (FABP4) (Fig. 1A) during a 13-day in vitro differentiation pro-
tocol. As shown in Fig. 1A, Oil-red O staining revealed the formation of
mature lipid-ﬁlled adipocytes that increased in number throughout dif-
ferentiation period. By determining the G-actin/F-actin ratio, we ob-
served that monomeric G-actin was increased from 59% to 76% and
assembled F-actin decreased from 42% to 24% during the adipocyte dif-
ferentiation (day 0 and day 13 values, respectively) (Fig. 1B).
Since actin cytoskeleton is regulated by RhoA/LIMK1/CFL1 axis
(Maekawa et al., 1999), we examined their expression and activity dur-
ing adipocyte differentiation (Fig. 1C). We observed that the ratio of
phosphor-CFL1 (p-CFL1) to total CFL1 indicating accumulation of the in-
active form of CFL1 lacking the ability to disassemble actin ﬁbres, de-
creased during adipogenic induction mostly and this was caused by
highly increased expression of total CFL1 as soon as adipogenic induc-
tion started (Fig. 1C). The total and phosphorylation level of LIMK1, as
well as the expression of RhoA, which are the upstream kinases respon-
sible for CFL1 phosphorylation, were also reduced during adipocyte dif-
ferentiation (Fig. 1C). The expression of another actin depolymerisation
factor DSTN was unchanged (Fig. 1C). The results suggest that the ob-
served decreased in assembled actin during adipocyte differentiation
was associated with changes in RhoA/LIMK1/CFL1 signaling pathway.
3.2. Modulation of actin polymerization regulates adipocyte differentiation
of hMSCs
To corroborate the importance of actin assembly for adipocyte dif-
ferentiation, we examined the effects of cytochalasin D (CytoD) or
Phalloidin, which have been shown to dissemble or stabilize the actin
cytoskeleton in hMSCs, respectively (Chen et al., 2015), on adipocyte
differentiation of hMSCs. We observed that CytoD inhibited but
Phalloidin increased cell viability during adipocyte differentiation
(Fig. 2A). Disruption of actin assembly by CytoD increased the
Fig. 1. Actin cytoskeleton is dissembled during adipocyte differentiation of hMSCs via RhoA/LIMK1/CFL1 axis. hMSCs were treated with adipogenic induction medium for the indicated
days. Representative data were shown from three independent experiments. A. The expression of adipogenic markers were analyzed by qRT-PCR and normalized against B2M. The
expression level at day 13 was set to 1. Data were presented as mean + S.D., n = 3 (upper). Mature adipocytes with lipid droplets were stained by Oil-red O staining (lower). B. G-
actin and F-actin level were analyzed by G-actin/F-actin assay followed by quantitation of band density by ImageJ software. C. The expression and phosphorylation status of CFL1,
LIMK1, RhoA and DSTN was analyzed by western blot. α-tubulin was used as loading control. Band density in the Western blot was semi-quantitated by ImageJ software.
Fig. 2.Actin cytoskeletondynamics affects adipocyte differentiation of hMSCs. hMSCswere treatedwith DMSOas control, 0.5 μMCytochalasinD (Cyto D), or 3 μMPhalloidin as indicated in
Material and Methods, underwent adipocyte differentiation for 10 days. Representative data were shown from three independent experiments. *P b .05, **P b .01. A. Cell viability was
measured by CellTiter-Blue reagent. Data were presented as mean ± S.D., n = 8. B. The expression of adipogenic markers including ADIPOQ, LPL, PPARG and FABP4 was determined
by qRT-PCR and normalized against B2M. The expression level with DMSO treatment was set to 1. Data were presented as mean + S.D., n= 3. C. The accumulation of lipid droplets in
mature adipocytes was visualized by Oil-red O staining on Day 10 for Cyto D treatments and Day 13 for Phalloidin treatments.
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ber of mature adipocytes (Fig. 2C, left). In contrast, stabilization of actin
cytoskeleton by Phalloidin inhibited adipocyte differentiation evi-
denced by reduced expression of adipocytic gene markers (Fig. 2B) as
well as reduced number ofmature adipocytes (Fig. 2C, right). Similar re-
sults were also got from the culturing human primary bonemarrow de-
rived MSC and adipose-derived MSC (data not shown).3.3. Prevention of actin disassembly by knocking down CFL1 and DSTN in-
hibits adipocyte differentiation of hMSCs
To further conﬁrm the effects of actin dynamic status on adipocyte
differentiation, we stabilized actin cytoskeleton by decreasing levels of
CFL1 and DSTN using the speciﬁc siRNA (siR) and investigated the ef-
fects on adipocyte differentiation. siR-CFL1 and siR-DSTN resulted in
N80% decrease in levels of CFL1 and DSTN (Fig. 3A) and signiﬁcant
changes in cell viability (Fig. 3B). Cells deﬁcient in CFL1 or DSTN exhib-
ited signiﬁcant reduction in their adipocyte differentiation capacity
(Fig. 3C).3.4. Inhibition of LIMK1 increased adipocyte differentiation of hMSCs
LIMK1 phosphorylates CFL1 at Ser3 and thus inhibits its actin sever-
ing activity (Arber et al., 1998). We treated hMSCs with LIMK inhibitor
(LIMKi) during adipocyte differentiation and as expected, CFL1 phos-
phorylation was inhibited (Fig. 4A). LIMKi treatment enhanced adipo-
cyte differentiation and signiﬁcantly increased the expression ofFig. 3. Stabilization of actin cytoskeleton by knocking down CFL1 and DSTN inhibits adipogenes
targeting CFL1 (siR-CFL1), DSTN (siR-DSTN) or both and then treated with adipogenic induct
experiments. *P b .05, **P b .01. A. Knocking down efﬁciency was determined by qRT-PCR and
Data were presented as mean ± S.D., n = 3. B. Cell viability was measured by CellTiter-Blue
markers including ADIPOQ, LPL, PPARG and FABP4 was determined by qRT-PCR and normali
were presented as mean + S.D., n= 3. The accumulation of lipid droplets in mature adipocyteadipocyte genemarkers CEBPA, FABP4 and ADIPOQ and to lesser degree
of PPARG2 and LPL (Fig. 4C).
3.5. Actin assembly dynamics regulate adipocyte differentiation of hMSCs
via ERK and Smad2 signaling
We investigated signaling pathways associated with changes in
actin microﬁlament dynamics during adipocyte differentiation. De-
creased assembled actin by CytoD treatment decreased Smad2 and
ERK MAPK phosphorylation, while stabilized assembled actin by
Phalloidin treatment exerted opposite effects (Fig. 5A). In addition, we
treated the cells by speciﬁc ERK phosphorylation inhibitor U0126 (Fig.
5B) and we observed reversal of the inhibitory effects on adipocyte dif-
ferentiation by Phalloidin (Fig. 5C and D). We did not detect signiﬁcant
changes of Akt, Smad1/5/8, p38 or JNKMAPKs signaling pathways upon
treatment with CytoD or Phalloidin (data not shown).
4. Discussion
Changes in hMSCs cell morphology correlate with in vitro and in
vivo differentiation to osteoblasts and adipocytes. In the current study,
we demonstrated that adipocyte differentiation of hMSCs is associated
with signiﬁcant changes in actin ﬁlament structure with increased G-
monomeric actin and decreased F-actin and that these changeswere ac-
companied by changes in actin depolymerizing factor CFL1 which in-
volves in upstream kinase LIMK1 and downstream ERK kinase.
Actin cytoskeleton undergoes cycles of actin assembly and disas-
sembly in a balanced fashion between two states: a monomeric stateis of hMSCs. hMSCs were transfected with control non-targeting siRNA (siR-Ctrl) or siRNA
ion medium for up to 13 days. Representative data were shown from three independent
normalized against B2M at indicated day. The gene expression with siR-Ctrl was set to 1.
reagent. Data were presented as mean ± S.D., n = 8. C. The expression of adipogenic
zed against B2M at day 10 (upper). The expression level with siR-Ctrl was set to 1. Data
s was visualized by Oil-red O staining at day 10 (Lower).
Fig. 4. Inhibition of LIMK1 increased adipocyte differentiation of hMSCs by activation of CFL1. hMSCswere treatedwith adipogenic inductionmediumsupplementedwith DMSO as control
(Ctrl) or 1 μM LIMK inhibitor (LIMKi) for 7 or 10 days continuously. Representative data was shown from three independent experiments. **P b .01. A. The total and phosphor-CFL1 were
detected bywestern blot. Actinwas used as loading control. B. The accumulation of lipid droplets inmature adipocytes was visualized by Oil-red O staining at day 10. C. The expression of
adipogenic markers including CEBPA, ADIPOQ, LPL, PPARG and FABP4 was determined by qRT-PCR and normalized against B2M. Data were presented as mean ± S.D., n= 3.
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observed that adipocyte differentiation of hMSCs is associated with in-
creased in G-actin and these changes were the opposite of what we
have previously reported during osteoblastic differentiation of hMSC
(Chen et al., 2015). Since G-actin/F-actin is important determinant of
cell shape, our ﬁndings corroborate previous studies showing that
restructuring of cellular morphology during differentiation inﬂuences
lineage-speciﬁc commitment (Carvalho et al., 1998; McBeath et al.,
2004; Spiegelman and Ginty, 1983).
We observed signiﬁcant changes in actin depolymerizing
factors during hMSCs differentiation into adipocytes. CFL1 is ubiqui-
tously expressed, actin depolymerizing factor that limits actin
polymerization by binding (the non-phosphorylated form) to
F-actin without capping and severe the F-actin into monomers free
ends actin (G-actin) (Arber et al., 1998). CFL1 activity depends on
serine 3 phosphorylation mediated by LIM kinase (LIMK), which in
turn regulated by the Rho small GTPase and Rho-associated protein
kinase (ROCK) (Maekawa et al., 1999). We observed that high levels
of non-phosphorylated CFL1, and low level of LIMK1 and RhoA en-
hance adipocyte differentiation and lead to cellular enrichment of
depolymerized actin.
We have previously reported that stabilizing F-actin microﬁlaments
by Phalloidin or siRNAs-mediated decreased levels of CFL1 and DSTN
enhanced osteoblast differentiation of hMSCs and heterotopic bone for-
mation in vivo, while disruption of actin cytoskeleton by CytoD or inhi-
bition of LIMK1 activity decreased osteoblast differentiation. In the
current study, we observed opposite molecular changes associated
with adipocyte differentiation i.e. enhancing actin F-ﬁlament stabiliza-
tion inhibited adipocyte differentiation and decreased actin assembly
enhanced adipocyte differentiation. These studies suggest an inverse re-
lationship between the actin assembly state and the osteoblastic versus
adipocytic differentiation potential of hMSC. A recent study reported
that reduction of actin depolymerisation by CytoD treatment enhances
commitment to both osteoblastic and adipocytic lineage based on in-
creased expression of lineage speciﬁc markers and that a single intra-
tibial injection of CytoD enhances bone formation and bonemarrow ad-
ipocyte formation (Sen et al., 2015, 2017). This discrepancy may becaused by differences in cellular composition of MSC cultures and/or
culture conditions (short term versus long term treatment). Interest-
ingly, our measurements of G/F actin during lineage differentiation in
hMSCs showed similar reduction in actin polymerization (with in-
creased G-actin in cells) during the ﬁrst 3 days of osteoblast and adipo-
cyte differentiation suggesting that initial differentiation phase of
hMSCs and prior to speciﬁc lineage commitment associated with de-
creased actin assembly which is consistent with the published work of
Sen et al. (2017). These authors reported that short-term treatment
with CytoD increased the availability of G-actin and enhanced G-actin
translocation to the nucleus that increased gene expression of both os-
teoblastic and adipogenic differentiation (Sen et al., 2017). However,
different changes were observed later during the differentiation with
formation of enriched cytoplasmic F-actin (Chen et al., 2015) and
branching of nuclear actin that are associated with enhanced osteoblast
differentiation. In addition, our ﬁndings of the presence of an inverse
actin microﬁlaments dynamics during osteoblast versus adipocyte dif-
ferentiation is more consistent with the notion of hMSCs lineage alloca-
tion to osteoblastic or adipocytic cells occur at the level of stem cells
early during differentiation and associated with signiﬁcant cytoskeletal
changes (McBeath et al., 2004).
Changes in actin microﬁlaments are mediated by changes in extra-
cellular matrix, mechanical stimulation or growth factors intracellular
signaling. We observed signiﬁcant changes in a number of intracellular
signaling pathways associated with changes in actin dynamics during
hMSCs differentiation. During adipocyte differentiation, decreased in
actin assembly was associated with signiﬁcant changes in Smad2 and
ERK MAPK activation. Smad2 has been reported as a transcriptional
modulator that represses CEBP activation which is an adipocyte master
transcriptional factor. Consistent with this notion, we observed inhibi-
tion of Smad2 activation by CytoD and the enhancement of Smad2 acti-
vation by Phalloidin, suggested Smad2 signaling might be involved in
the regulation of adipogenic differentiation of actin assembly. While
SB431546, a TGFR inhibitor that inhibits TGF/Smad2 activation in cells,
did not rescued the inhibition of adipogenic differentiation by
Phalloidin, either the activation of phos-Smad2 activation by Phalloidin
and adipogenic induction (data not shown), suggested the Smad2
Fig. 5. Actin dynamics affects adipogenesis through ERK and Smad2. A. hMSCs was treated with DMSO as control, 0.5 μM Cytochalasin D (CytoD) or 3 μM Phalloidin and then underwent
adipocyte differentiation for 10 days. The expression of total and phosphor-Smad2 and ERKwere detected bywestern blot.α-tubulinwas used as loading control. B–D. hMSCswas treated
with adipogenic induction medium alone or in the presence of 3 μM Phalloidin without or with either 10 or 25 μM ERK inhibitor U0126. The total and phosphor-ERK were detected by
western blot. α-tubulin was used as loading control (B). The expressions of adipogenic markers including CEBPA, ADIPOQ, LPL, PPARG and FABP4 were determined by qRT-PCR and
normalized against B2M. Data was presented as mean ± S.D., n = 3 (C). The accumulation of lipid droplets in mature adipocytes was visualized by Oil-red O staining (D).
Representative data was shown from three independent experiments. *P b .05, **P b .01.
81L. Chen et al. / Stem Cell Research 29 (2018) 76–83activation by Phalloidin (actin polymerization) during adipogenic in-
duction might not related with TGFβ-TGFR pathways. Actin cytoskele-
ton has been reported to affect ERK activation in cell type dependent
manner (Ailenberg and Silverman, 2003). In MSC, Muller et al. reported
that CytoD enhances adipocyte differentiation in presence of mechani-
cal stimulation and that these effects were associated with Akt but not
ERK activation, while another actin depolymerizing reagent latrunculin
A (LatA) blocked both Akt and ERK activation (Muller et al., 2013). We
did not detected clear changes at activation of AKT, p38 or JNK by
CytoD or Phalloidin in hMSCs during adipogenic differentiation (data
not shown). These results indicate there are multiple signaling path-
ways associated with actin cytoskeletal changes dependent on cell
type and culture conditions.
Changes in actin microﬁlament assembly and disassembly are asso-
ciatedwith several cellular functions including cell cycle, morphological
maintenance, cell attachment and adhesion, and cell locomotion which
are determining factors for cellular differentiation fate (McBeath et al.,
2004). While changing cell shape of hMSCs inﬂuences differentiationpotential of the cells as demonstrated in a number of studies where
MSC were cultured on substrates of different stiffness (Engler et al.,
2006). This approach has been utilized in tissue engineering protocols
with the aim of controlling differentiation of MSC through engineering
physical cues on cell culture surfaces or through exposing the cells to
mechanical stimulation (Kshitiz et al., 2012). Our current study and pre-
vious study (Chen et al., 2015) demonstrate that by targeting themolec-
ular mechanisms responsible for actin microﬁlaments assembly, it is
possible to direct the differentiation fate of MSC into osteoblast or adi-
pocytes. Thus, targeting intracellular molecular machinery responsible
for cytoskeletal homoeostasis is a plausible approach for controlling dif-
ferentiation fate of MSC and is relevant approach for regenerative med-
icine applications (Fig. 6).
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